Blog

Sun Pharma said its formulation sales in India were at Rs 4,835.9 crore, registering a growth of 14.8 per cent in the fourth quarter, accounting for 33.2 per cent of total consolidated sales. For the full year FY26, India formulations sales were at Rs 19,290.4 crore, a growth of 14 per cent YoY.